Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Talaris Therapeutics (TALS) News Today

Talaris Therapeutics logo

TALS Latest News

Tourmaline Bio, Inc. (TRML)
Longitude Venture Partners III, L.P.'s Net Worth
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETI
Talaris Therapeutics announces merger after layoffs
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIR
Talaris to merge with Tourmaline Bio in all-stock deal
Tourmaline, Talaris Announce All-stock Merger
Talaris Therapeutics (Nasdaq:TALS) Headline
Trading was temporarily halted for "TALS" at 07:06 AM with a stated reason of "News pending."...
Talaris Therapeutics Announces Leadership Transition
Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.

TALS Media Mentions By Week

TALS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TALS
News Sentiment

0.00

0.58

Average
Medical
News Sentiment

TALS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TALS Articles
This Week

0

0

TALS Articles
Average Week

Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TALS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners